The Role of TLR4 on Lipid-induced Insulin Resistance
Status:
Completed
Trial end date:
2018-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether pharmacologic inhibition of Toll-like
receptor 4 (TLR4) with eritoran for injection (E5564) prevents lipid-induced insulin
resistance in lean, normal glucose tolerant (NGT) subjects.
Phase:
Phase 2
Details
Lead Sponsor:
The University of Texas Health Science Center at San Antonio